← Back to all signals
RESEARCH PAPER ANALYSIS

Helmut Gadner: A Charismatic Leader, Visionary, and Pioneer in Pediatric Oncology.

AI interpretation is pending for this paper.

Open original publication →
PMID39371893
JournalCureus
Publication Date2024-09-04
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Helmut Gadner, a world-famous pediatric hematologist-oncologist, dedicated his professional life to researching pediatric cancer and advancing care for affected children, adolescents, and their families. Starting his career in the team of Hansjörg Riehm, the father of the ever-most successful BFM (abbreviation of the city names of the founding institutions, Berlin-Frankfurt-Münster) treatment concept of pediatric leukemia, the young Dr. Gadner became a passionate soldier in the fight against pediatric cancer. From 1980 to 2010, he served as a medical director of St. Anna Children's Hospital in Vienna, Austria. Soon after taking this highly responsible position, he realized that improving patient care requires rigorous research from bench to bedside. In 1988, he and others founded St. Anna Children's Cancer Research Institute (St. Anna CCRI), a testament to his visionary spirit, which he headed until his retirement in 2012. His thoughtful leadership and vision were instrumental in establishing St. Anna Children's Hospital and St. Anna CCRI as a worldwide acclaimed center for researching, diagnosing, and treating children and adolescents with cancer within the environment of national and international collaborations and clinical trials. Dr. Gadner's enduring legacy, St. Anna CCRI, recently celebrated its 35th anniversary, operating 14 research groups actively engaged in global collaboration and a wide range of research fields, from basic molecular research to prospective international clinical trials. Helmut Gadner was chair of the Austrian National Working Group for Pediatric Hematology and Oncology (AGPHO) for many years. The outstanding survival of children with acute lymphoblastic leukemia in Austria, placing pediatric oncology in this small country at the top of Europe and the world, is the best evidence of his dedicated and perseverant leadership in this position. Dr. Gadner's lifetime achievements as a scientist, physician, mentor, and leader have received many national and international awards, and herein we try to provide a summary.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Beginning Restorative Activities Very Early: A Quality Improvement Project to Advance ABCDEF Bundle Practice in a Pediatric Oncology Intensive Care Unit. Pediatric reports 63.9 2 Developing Odontoma with Radiolucency in the Maxillary Right Second Molar. Reports (MDPI) 56.4 3 A New Horizon: Expanding the Access and Impact of Psychosocial Oncology-8-9 June 2026, 41st Annual CAPO Conference. Current oncology (Toronto, Ont.) 61.9 4 The Cervical Cancer Paradox in Eastern Europe: How Knowledge and Institutional Trust Shape HPV Vaccination Attitudes in Romania. Medical sciences (Basel, Switzerland) 59.5 5 Building Physician Capacity for HPV Vaccine Uptake in India: Mixed-Methods Implementation Outcomes of a Train-the-Trainer Model Using RE-AIM. Vaccines 61.4 6 The Interplay of Quality of Life and Satisfaction with Nursing Care in Cancer Patients: A Narrative Review. Clinics and practice 58.2 7 A Temporal Candidemia Cluster in a Jordanian Pediatric Oncology Unit: Clinical Characterization, Putative Environmental Sources, and Multidisciplinary Infection Control Responses-A Single-Center Pilot Study. Journal of fungi (Basel, Switzerland) 67.02 8 Clinical Characteristics and Outcomes of Surgical Treatment of Solitary Osteochondromas in Children: A 11-Year Retrospective Study. Medical sciences (Basel, Switzerland) 69.24 9 Assessment of the Environmental Impact of Uranium Mining Sites: A Case Study of a Uranium Deposit in Southern Kazakhstan. Toxics 57.5 10 Intra-Axial Cerebral Schwannoma in a Child: A Case Report. Neurology international 47.5 11 Age-Specific Radiological Risk of 222Rn in Drinking Water Wells Along the Sultandağı Fault Zone (Türkiye): A One-Year Monitoring Study. Toxics 57.2 12 Robotic approach for Wilms' tumour: Patient selection, technical considerations, and outcome analysis. Journal of pediatric urology 61.9 13 Stridor and Dysphagia Unmasking an Aberrant Right Subclavian Artery in a Toddler. Clinical practice and cases in emergency medicine 61.9 14 Knowledge, Attitudes, and Practices (KAP) Regarding Sexually Transmitted Infections, Human Papillomavirus, and HPV-Related Oropharyngeal Cancer Among Italian Adolescents: A Cross-Sectional Study. Dentistry journal 61.0 15 Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report. Hematology reports 61.0 16 Factors Affecting Temporal Changes in Ablated Liver Volume After Radiofrequency Ablation for Hepatocellular Carcinoma Evaluated by Three-Dimensional Volumetric Computed Tomography. Tomography (Ann Arbor, Mich.) 59.5 17 Bibliometric Analysis of Whole-Body MRI from 2015 to 2025 Across Clinical Applications, Quantitative Imaging, and Artificial Intelligence. Journal of imaging 56.0 18 Case Report: Clinical analysis and literature review of two cases of high-grade adult-type cervical embryonal rhabdomyosarcoma. Frontiers in oncology 62.3 19 Integrin β1 signaling at the crossroads of cellular plasticity, the tumor microenvironment, and therapy resistance in medulloblastoma. Frontiers in oncology 64.44 20 Real-World Data on Characteristics and Management of Patients with Actinic Keratosis: A Cancer Center Experience. Medical sciences (Basel, Switzerland) 70.1 21 Real-World Evidence of Disproportionate Financial Toxicity and Health-Related Social Needs Among Adolescents and Young Adults Receiving Care at an NCI-Designated Cancer Center. Current oncology (Toronto, Ont.) 70.62 22 Anticancer Activity of Green Synthesized ZnO Nanoparticles from Ficus benghalensis Bark in Osteosarcoma Cells. Nanomaterials (Basel, Switzerland) 56.9 23 Deep learning segmentation of paediatric brain tumours using diffusion-weighted MRI: towards an early, in vivo classification pipeline. Brain communications 62.5 24 Genomic Characterization of Epigenetic Regulator Gene Alterations in Juvenile Myelomonocytic Leukemia Through Whole-Exome Sequencing. Epigenomes 61.5 25 Exploring the Social and Stigma-Related Lived Experiences of Pediatric Cancer Survivors in a Canadian Province. Current oncology (Toronto, Ont.) 68.0 26 Knowledge, Attitudes, and Practices Related to Radiotherapy and Chemotherapy Among Women with Cervical Cancer: A Cross-Sectional Study. Journal of multidisciplinary healthcare 71.24 27 Radiological Findings and Genetic Rearrangements in Paediatric Patients with Acute Lymphoblastic Leukaemia. The application of clinical genetics 67.0 28 Comparison of clinical characteristics between children and adults with adrenal mass. Discover oncology 68.0 29 The quiet flame: whole-body MRI and the underestimated burden of pediatric chronic non-bacterial osteomyelitis (CNO). European journal of pediatrics 65.0 30 Radiological hazard assessment of radionuclides in packaged non-alcoholic beverages commonly consumed in Türkiye. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 58.7 31 Machine Learning Modeling for Predicting Mortality in Pediatric Patients Undergoing Elective Noncardiac Surgery: Comparison to a Regression Model. Anesthesia and analgesia 71.0 32 Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial. European journal of pediatrics 69.14
PATIENT-FRIENDLY SUMMARY

Helmut Gadner: A Charismatic Leader, Visionary, and Pioneer in Pediatric Oncology.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic